Historical record - last NADAC publication: 8/21/2019
Product Information
QUETIAPINE FUMARATE 300 MG TAB is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.1973 per EA under NDC 00054022320. Its NADAC has been published 286 times since Mar 12, 2014.
Strength
300 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054022320
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
8/21/2019
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA090749On Market Since
3/27/2012
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE FUMARATE 300 MG TAB has been published 286 times since Mar 12, 2014, and over the history we have for it it has declined 56.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1973 per EA |
|---|---|
| All-time high | $0.4521 (Mar 12, 2014) |
| All-time low | $0.1702 (Apr 17, 2019) |
| Median price | $0.3076 |
| Average price | $0.3030 |
| Largest weekly change | +18.4% (Oct 17, 2018) |
| Weeks tracked | 286 |
| Tracking since | Mar 12, 2014 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of QUETIAPINE FUMARATE 300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE FUMARATE 300 MG TAB, manufactured by Hikma Pharmaceuticals USA Inc., is $0.1973 per EA (NDC 00054022320), effective Aug 28, 2019.
How has the price of QUETIAPINE FUMARATE 300 MG TAB changed over time?
Over the history we have for it, the NADAC for QUETIAPINE FUMARATE 300 MG TAB has declined 56.4%. It has been tracked across 286 weekly CMS publications since Mar 12, 2014.
What are the highest and lowest recorded NADAC prices for QUETIAPINE FUMARATE 300 MG TAB?
Since Mar 12, 2014, the NADAC for QUETIAPINE FUMARATE 300 MG TAB has ranged from a low of $0.1702 (Apr 17, 2019) to a high of $0.4521 (Mar 12, 2014), with a median of $0.3076 per EA.
Are there cheaper alternatives to QUETIAPINE FUMARATE 300 MG TAB?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, QUETIAPINE FUMARATE 300 MG TAB, is $0.1396 per EA — about 29% below QUETIAPINE FUMARATE 300 MG TAB.
Who manufactures QUETIAPINE FUMARATE 300 MG TAB?
QUETIAPINE FUMARATE 300 MG TAB (NDC 00054022320) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification